![Matthew Balk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Balk
Nessuna posizione attualmente
Profilo
Matthew Balk is the founder of Entero Therapeutics, Inc. Mr. Balk was an Independent Director at Vivakor, Inc. from 2020 to 2023.
Mr. Balk was a Director at Adapti, Inc. from 2024 to 2025.
Balk earned an MBA from The Leonard N Stern School of Business.
Precedenti posizioni note di Matthew Balk
| Società | Posizione | Fine |
|---|---|---|
| ADAPTI, INC. | Direttore/Membro del Consiglio | 25/10/2025 |
| VIVAKOR, INC. | Direttore/Membro del Consiglio | 16/01/2023 |
| GRIDAI TECHNOLOGIES CORP. | Fondatore | - |
Formazione di Matthew Balk
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Scepter Holdings, Inc.
 Scepter Holdings, Inc. Household/Personal CareConsumer Non-Durables Manufactures and sells consumer packaged goods | Consumer Non-Durables |
Vivakor, Inc.
 Vivakor, Inc. Chemicals: SpecialtyProcess Industries Operates as an asset acquisition company, which acquires technologies and assets in the fields of precious minerals, biotechnology and alternative energy | Process Industries |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entero Therapeutics, Inc.
 Entero Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures non-systemic therapies for the treatment of patients with gastrointestinal diseases | Health Technology |
